- Home
- AQST vs EVAC Comparison
AQST vs EVAC Comparison
Compare AQST & EVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.92
N/A
Current Price
$10.03
Company Overview
Basic Information| Metric | AQST | EVAC |
|---|---|---|
| Founded | 2004 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Fluid Controls |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.6M | 584.5M |
| IPO Year | 2018 | 2025 |
Fundamental Metrics
Financial Performance| Metric | AQST | EVAC |
|---|---|---|
| Price | $3.92 | $10.03 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $8.83 | N/A |
| AVG Volume (30 Days) | ★ 4.3M | 39.5K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $43,397,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $52.34 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.12 | $9.90 |
| 52 Week High | $7.55 | $10.17 |
Technical Indicators
Market Signals| Indicator | AQST | EVAC |
|---|---|---|
| Relative Strength Index (RSI) | 22.22 | N/A |
| Support Level | $5.86 | N/A |
| Resistance Level | $6.59 | N/A |
| Average True Range (ATR) | 0.32 | 0.00 |
| MACD | -0.13 | 0.00 |
| Stochastic Oscillator | 11.98 | 0.00 |
Price Performance
Historical Comparison AQST
EVAC
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About EVAC EQV Ventures Acquisition Corp. II Class A Ordinary Shares
EQV Ventures Acquisition Corp II is a blank check company.